News

business partnership handshake merger acquisition M&A

The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.

Thumbnail

No other heart or transplant services at the nonprofit hospital should be impacted by this temporary shift in care. 

The collaboration allows providers to order diagnostic tests and then receive results directly in Epic.

Much more research is still required, but a new meta-analysis in Stroke suggests these medications may provide valuable stroke prevention.

Caon Medical USA ultrasound director Dan Skyba explains advances in ultrasound processing algorithms at RSNA 2025.

The U.S. Food and Drug Administration has green-lit new updates that improve microvascular flow, AI-assisted harmonic imaging and elastography, which Canon will showcase at RSNA 2025.

breast cancer month ribbon

The Find It Early Act would ensure all women have access to supplemental exams, such as ultrasound and MRI, with no out-of-pocket costs.

Financial data showing growing revenue

The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward. 

small hospital

One of the AI haves feels the pain of the AI have-nots. His discomfort is especially pronounced when he thinks about how hard it must be for financial strugglers to keep up with regulations and rumors of regulations to come.

Medicare data stethoscope healthcare trends graphs finance financials

The ACR's Neiman Policy Institute believes residency slot increases and reductions in inappropriate imaging orders are needed to counter these trends. 

Thumbnail

“When healthcare prices are hidden, large corporate entities like hospitals and insurance companies benefit," the White House said.  

US army parachute military man

The Lexington, Massachusetts, company will outfit multiple federal facilities with its imaging solution beginning in Q1. 

AI pain management

We have seen the future of pain management, and it is in automated assessments aided by AI.

Around the web

The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.

No other heart or transplant services at the nonprofit hospital should be impacted by this temporary shift in care. 

The collaboration allows providers to order diagnostic tests and then receive results directly in Epic.